793 related articles for article (PubMed ID: 33726839)
1. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
2. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
[TBL] [Abstract][Full Text] [Related]
3. Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice.
Jury N; Abarzua S; Diaz I; Guerra MV; Ampuero E; Cubillos P; Martinez P; Herrera-Soto A; Arredondo C; Rojas F; Manterola M; Rojas A; Montecino M; Varela-Nallar L; van Zundert B
Clin Epigenetics; 2020 Feb; 12(1):32. PubMed ID: 32070418
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
McEachin ZT; Gendron TF; Raj N; García-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K; Hales CM; García-Sobrino T; Quintáns B; Holler CJ; Taylor G; San Millán B; Teijeira S; Yamashita T; Ohkubo R; Boulis NM; Xu C; Wen Z; Streichenberger N; ; Fogel BL; Kukar T; Abe K; Dickson DW; Arias M; Glass JD; Jiang J; Tansey MG; Sobrido MJ; Petrucelli L; Rossoll W; Bassell GJ
Neuron; 2020 Jul; 107(2):292-305.e6. PubMed ID: 32375063
[TBL] [Abstract][Full Text] [Related]
5. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
[TBL] [Abstract][Full Text] [Related]
6. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.
Beckers J; Tharkeshwar AK; Van Damme P
Autophagy; 2021 Nov; 17(11):3306-3322. PubMed ID: 33632058
[TBL] [Abstract][Full Text] [Related]
7. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
8. Loss of TMEM106B exacerbates C9ALS/FTD DPR pathology by disrupting autophagosome maturation.
Bauer CS; Webster CP; Shaw AC; Kok JR; Castelli LM; Lin YH; Smith EF; Illanes-Álvarez F; Higginbottom A; Shaw PJ; Azzouz M; Ferraiuolo L; Hautbergue GM; Grierson AJ; De Vos KJ
Front Cell Neurosci; 2022; 16():1061559. PubMed ID: 36619668
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
[TBL] [Abstract][Full Text] [Related]
10. Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G
Czuppa M; Dhingra A; Zhou Q; Schludi C; König L; Scharf E; Farny D; Dalmia A; Täger J; Castillo-Lizardo M; Katona E; Mori K; Aumer T; Schelter F; Müller M; Carell T; Kalliokoski T; Messinger J; Rizzu P; Heutink P; Edbauer D
Cell Rep; 2022 Jun; 39(10):110913. PubMed ID: 35675776
[TBL] [Abstract][Full Text] [Related]
11. C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity.
Lee YB; Baskaran P; Gomez-Deza J; Chen HJ; Nishimura AL; Smith BN; Troakes C; Adachi Y; Stepto A; Petrucelli L; Gallo JM; Hirth F; Rogelj B; Guthrie S; Shaw CE
Hum Mol Genet; 2017 Dec; 26(24):4765-4777. PubMed ID: 28973350
[TBL] [Abstract][Full Text] [Related]
12. Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G
Bush JA; Aikawa H; Fuerst R; Li Y; Ursu A; Meyer SM; Benhamou RI; Chen JL; Khan T; Wagner-Griffin S; Van Meter MJ; Tong Y; Olafson H; McKee KK; Childs-Disney JL; Gendron TF; Zhang Y; Coyne AN; Wang ET; Yildirim I; Wang KW; Petrucelli L; Rothstein JD; Disney MD
Sci Transl Med; 2021 Oct; 13(617):eabd5991. PubMed ID: 34705518
[TBL] [Abstract][Full Text] [Related]
13. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders.
Mis MSC; Brajkovic S; Tafuri F; Bresolin N; Comi GP; Corti S
Mol Neurobiol; 2017 Aug; 54(6):4466-4476. PubMed ID: 27349438
[TBL] [Abstract][Full Text] [Related]
14. Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models.
Liang C; Shao Q; Zhang W; Yang M; Chang Q; Chen R; Chen JF
Hum Mol Genet; 2019 Dec; 28(23):3940-3953. PubMed ID: 31625563
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) promotes toxicity of
Gao J; Mewborne QT; Girdhar A; Sheth U; Coyne AN; Punathil R; Kang BG; Dasovich M; Veire A; DeJesus Hernandez M; Liu S; Shi Z; Dafinca R; Fouquerel E; Talbot K; Kam TI; Zhang YJ; Dickson D; Petrucelli L; van Blitterswijk M; Guo L; Dawson TM; Dawson VL; Leung AKL; Lloyd TE; Gendron TF; Rothstein JD; Zhang K
Sci Transl Med; 2022 Sep; 14(662):eabq3215. PubMed ID: 36103513
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
[TBL] [Abstract][Full Text] [Related]
18. Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia.
Stepto A; Gallo JM; Shaw CE; Hirth F
Acta Neuropathol; 2014 Mar; 127(3):377-89. PubMed ID: 24366528
[TBL] [Abstract][Full Text] [Related]
19. Poly-GP in cerebrospinal fluid links
Lehmer C; Oeckl P; Weishaupt JH; Volk AE; Diehl-Schmid J; Schroeter ML; Lauer M; Kornhuber J; Levin J; Fassbender K; Landwehrmeyer B; ; Schludi MH; Arzberger T; Kremmer E; Flatley A; Feederle R; Steinacker P; Weydt P; Ludolph AC; Edbauer D; Otto M
EMBO Mol Med; 2017 Jul; 9(7):859-868. PubMed ID: 28408402
[TBL] [Abstract][Full Text] [Related]
20. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration.
Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F
Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
